Biomarker Card
This biomarker card gives comprehensive information about each biomarker.
| Detailed Information | |
|---|---|
| Biomarker ID | 701 |
| PMID | 21820414 |
| Year | 2011 |
| Biomarker | Annexin A5 |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Cell Lines |
| Subjects | Humans |
| Regulation | Upregulated in CD44++ Cells |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | CD44+ Vs CD44- Cells |
| Type of Biomarker | Prognostic |
| Cohort | DU145 prostate cancer cell line was isolated into CD44+ or CD44- cells.CD44+ cells possessed stem cell characteristics and highly expressed genes known to be important in stem cell maintenance |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | Western Blotting |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on human patient cohort |
| Technical Name | ANXA5 |